Péter Árkosy

563 total citations
32 papers, 440 citations indexed

About

Péter Árkosy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Péter Árkosy has authored 32 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Péter Árkosy's work include Pancreatic and Hepatic Oncology Research (6 papers), Prostate Cancer Treatment and Research (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Péter Árkosy is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Prostate Cancer Treatment and Research (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Péter Árkosy collaborates with scholars based in Hungary, United States and Poland. Péter Árkosy's co-authors include Judit Tóth, Éva Sebő, Borbála Kiss, Edit Mikó, Péter Bai, Gyula Ujlaki, Dezső Tóth, Gábor Méhes, Tündé Kovàcs and Anita Boratkó and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Péter Árkosy

29 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Árkosy Hungary 9 285 156 67 52 51 32 440
Patrik Kovács Hungary 8 314 1.1× 192 1.2× 86 1.3× 40 0.8× 73 1.4× 14 489
Timothy Carroll United States 9 314 1.1× 171 1.1× 59 0.9× 27 0.5× 67 1.3× 11 468
Yuchen Zhang China 12 295 1.0× 164 1.1× 49 0.7× 52 1.0× 125 2.5× 40 585
Wonwoo Kim South Korea 13 128 0.4× 109 0.7× 137 2.0× 55 1.1× 37 0.7× 31 398
Richard Weinshilboum United States 11 214 0.8× 188 1.2× 33 0.5× 74 1.4× 61 1.2× 31 530
Almudena Chaves Perez United States 9 176 0.6× 165 1.1× 41 0.6× 27 0.5× 71 1.4× 13 404
Fei Xiong China 14 306 1.1× 94 0.6× 72 1.1× 43 0.8× 117 2.3× 39 526
Wenyue Liu China 9 266 0.9× 63 0.4× 27 0.4× 32 0.6× 88 1.7× 21 371
Balawant Kumar United States 11 238 0.8× 84 0.5× 26 0.4× 48 0.9× 77 1.5× 24 407
Rajneesh Pathania United States 7 468 1.6× 135 0.9× 52 0.8× 43 0.8× 124 2.4× 10 601

Countries citing papers authored by Péter Árkosy

Since Specialization
Citations

This map shows the geographic impact of Péter Árkosy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Árkosy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Árkosy more than expected).

Fields of papers citing papers by Péter Árkosy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Árkosy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Árkosy. The network helps show where Péter Árkosy may publish in the future.

Co-authorship network of co-authors of Péter Árkosy

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Árkosy. A scholar is included among the top collaborators of Péter Árkosy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Árkosy. Péter Árkosy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagy, Ágnes, Gábor Cserni, Péter Árkosy, et al.. (2025). Prognostic Potential of Apoptosis-Related Biomarker Expression in Triple-Negative Breast Cancers. International Journal of Molecular Sciences. 26(15). 7227–7227.
2.
Vaishampayan, Ulka N., Robert Dreicer, Elisabeth I. Heath, et al.. (2024). A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer. European Journal of Cancer. 202. 114007–114007. 3 indexed citations
3.
Soler, Rafaela, Ismael Macías, Alfonso Yubero, et al.. (2024). 9P Positive ad hoc results from neoadjuvant Foxy-5 treatment of colon cancer patients in the ongoing phase II NeoFox study. Annals of Oncology. 35. S6–S6. 1 indexed citations
4.
Bodoki, Levente, Attila Makai, Zsuzsanna Orosz, et al.. (2023). Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience. Frontiers in Oncology. 13. 1252215–1252215. 5 indexed citations
5.
Piasecki, Piotr, Chee Goh, Péter Árkosy, et al.. (2023). A novel abiraterone acetate oral suspension for patients with metastatic prostate cancer: An open-label, phase 3, randomized trial.. Journal of Clinical Oncology. 41(16_suppl). 5052–5052.
6.
Árkosy, Péter, et al.. (2023). A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with “bone-only” metastatic breast cancer. Pathology & Oncology Research. 29. 1611369–1611369. 2 indexed citations
7.
Rugo, Hope S., David W. Cescon, Mastura Md Yusof, et al.. (2023). 191MO KEYNOTE-355: Outcomes in patients who discontinued chemotherapy before pembrolizumab and in patients with immune-mediated AEs. ESMO Open. 8(1). 101380–101380. 2 indexed citations
8.
Nagy, János, et al.. (2022). A női és a férfiemlőrák standardizált incidencia- és mortalitásadatai Magyarországon 2000 és 2016 között. Orvosi Hetilap. 163(5). 181–186. 3 indexed citations
9.
Kiss, Borbála, Edit Mikó, Éva Sebő, et al.. (2020). Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma. Cancers. 12(5). 1068–1068. 49 indexed citations
10.
Szekanecz, Zoltán, Boglárka Soós, Levente Bodoki, et al.. (2020). Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases. Autoimmunity Reviews. 19(11). 102658–102658. 14 indexed citations
11.
Árkosy, Péter, Judit Tóth, Dezső Tóth, et al.. (2020). Prognosis and Treatment Outcomes of Patients Undergoing Resection of Brain Metastases from Breast Cancer. Anticancer Research. 40(3). 1759–1770. 3 indexed citations
12.
Sipka, Sándor, János Nagy, Judit Kocsis, et al.. (2020). Analysis of Low Cancer Mortality Rates in the Wine Regions of Tokaj and Balaton in Hungary. International Journal of Environmental Research and Public Health. 17(18). 6759–6759. 1 indexed citations
13.
Virga, József, Tibor Hortobágyi, Gábor Zahuczky, et al.. (2020). Az inváziós spektrum prognosztikai jelentôsége glioblastomában. Ideggyógyászati Szemle. 73(9-10). 317–325. 2 indexed citations
14.
Klekner, Álmos, et al.. (2019). Significance of liquid biopsy in glioblastoma – A review. Journal of Biotechnology. 298. 82–87. 31 indexed citations
15.
Németh, Norbert, Katalin Pető, Ádám Deák, et al.. (2019). Hemodynamic consequences of intravenously given E. coli suspension: observations in a fulminant sepsis model in pigs, a descriptive case–control study. European journal of medical research. 24(1). 11–11. 1 indexed citations
16.
Kovàcs, Tündé, Edit Mikó, András Vida, et al.. (2019). Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors. Scientific Reports. 9(1). 1300–1300. 143 indexed citations
17.
18.
Tóth, Dezső, et al.. (2017). Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary. Chinese Journal of Cancer Research. 29(4). 323–332. 14 indexed citations
19.
Takács, István, et al.. (2008). Mesohepatectomy without hilar dissection in the treatment of malignant focal liver diseases. University of Debrecen Electronic Archive (University of Debrecen). 2 indexed citations
20.
Szabó, László, et al.. (2006). Laparoscopic treatment of nonparasitic hepatic cysts. Surgical Endoscopy. 20(4). 595–597. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrik Kovács Breakdown of academic impact, for papers by Timothy Carroll Breakdown of academic impact, for papers by Yuchen Zhang Breakdown of academic impact, for papers by Wonwoo Kim Breakdown of academic impact, for papers by Richard Weinshilboum Breakdown of academic impact, for papers by Almudena Chaves Perez Breakdown of academic impact, for papers by Fei Xiong Breakdown of academic impact, for papers by Wenyue Liu Breakdown of academic impact, for papers by Balawant Kumar Breakdown of academic impact, for papers by Rajneesh Pathania
Rankless by CCL
2026